We recently published a list of 10 Stocks Insiders Sold in April After Trump’s Tariff Rollout. In this article, we are going to take a look at where Zai Lab Limited (NASDAQ:ZLAB) stands against other ...

Zai Lab (NasdaqGM:ZLAB) shares have drifted steadily lower over the past month, as investors weigh the company’s ongoing growth prospects against a challenging period for biotech stocks. Despite ...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for full-year 2023, along with recent product highlights and corporate ...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its fourth quarter and full year 2024 financial results and provide recent ...

Another competitor in the anti-CD47 race is throwing in the towel. Zai Lab has determined “due to the competitive landscape,” that internal development of monoclonal antibody ZL-1201 will be ...

Zai Lab collaborated with NovoCure on a study to treat non-small cell lung cancer. There were some concerns about the validity of the study. Zai Lab improved revenue by 36% year over year in the first ...

After linking arms with Mirati Therapeutics and MacroGenics in recent months, Zai Lab is once again making deals, this time signing an oncology R&D pact with molecule modeler Schrödinger that could ...

Zai Lab (ZLAB) announced on Wednesday that it plans to await the results of a trial evaluating Bemarituzumab in combination with Nivolumab and chemotherapy before filing for regulatory approval of the ...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for the novel antibacterial drug ...

Zai Lab is a commercial-stage biotech that saw revenue rise 33%, year over year, in the last quarter. The company is partnering with Swiss pharmaceutical Novocure on using Tumor Treating Fields to ...